Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Rae Cook/Axios

The world still needs more coronavirus vaccines, but an additional bottleneck has emerged in many low-income countries: They need help getting shots in arms.

Why it matters: Increasing vaccination rates across the world is both a humanitarian necessity and the best way to prevent dangerous new variants from emerging, but it increasingly requires complex problem-solving.

The big picture: Wealthy countries are vastly outpacing low and middle-income countries' vaccination rates because they've hoarded the lion's share of the world's doses.

  • But as more vaccine is shipped around the world, it's becoming increasingly clear that for a number of developing countries, administering doses may be nearly as challenging as obtaining them.

The state of play: Seth Berkley, CEO of the Gavi vaccine alliance and point person on the global COVAX initiative, tells Axios that most poor countries can absorb all the doses they're receiving, but when they run their weekly assessments "between 18 and 25 countries come up red."

  • The challenges range from shortages of supplies like syringes or health care workers to utilize them, issues with the "cold chain" needed to transport and store Pfizer and Moderna doses, vaccine hesitancy, or inadequate logistical planning, Berkley says.
  • In countries like the Democratic Republic of Congo, where 0.1% of the population has had the first dose, it can be all of the above.
  • Deliveries can also be unpredictable or arrive with little time before doses are set to expire. Among the 92 lower-income countries being supported by COVAX, half have used less than 75% of the doses they've received, according to an analysis from the COVID Global Accountability Platform.

What to watch: COVAX is working on a country-by-country basis to try to solve those challenges, Berkley says, whether that means sourcing equipment or sending in medical teams.

  • But they also consider a country's ability to distribute doses before they ship them, and he acknowledges that some countries with very low vaccination rates will only fall farther behind in the coming months.

Between the lines: Virtually no low-income countries are on track to vaccinate 40% of their population this year, the goal set by the WHO, according to a recent analysis by COVID GAP. Many will miss the 20% mark COVAX set as a minimum by the end of 2021.

  • Among the 92 COVAX-reliant countries, the median vaccination rate is just 11%.
  • There's currently a supply gap of 650 million doses, in addition to the hundreds of millions of doses that COVAX is still expected to deliver, the analysis estimates. Most of the countries awaiting doses are in sub-Saharan Africa or South Asia.

What's next: But that picture is changing rapidly. "We will stop seeing supply as a barrier pretty soon," Berkley says.

  • Heading into 2022, the conversation around global vaccinations will evolve into a much more complicated one than simply who has the doses and who doesn't.

Go deeper

19 hours ago - World

South Africa says it's being "punished" for detecting new COVID variant

South African Foreign Minister Naledi Pandor addresses the 76th Session of the U.N. General Assembly on September 22, 2021 in New York City. Photo: Eduardo Munoz - Pool/Getty Images)

South Africa said Saturday it's being "punished" for detecting the new Omicron coronavirus variant as more countries rush to enact travel bans and restrictions.

Driving the news: The U.S. imposed air travel restrictions from eight countries Friday in response to the Omicron variant. Countries in Europe and Asia have also implemented their own travel restrictions in response to Omicron.

Nov 26, 2021 - Health

U.S. to restrict air travel from 8 countries over new COVID variant concerns

A COVID-19 vaccine is administered. Photo by Joe Raedle/Getty Images

The U.S. will impose new air travel restrictions in response to the Omicron variant, a new COVID strain first detected in South Africa, President Biden announced Friday.

The big picture: Air travel from South Africa, Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique and Malawi will be restricted starting on Monday.

Updated Nov 26, 2021 - Health

Europe, Asia tighten borders in fear of new COVID variant

Passengers stand at the check-in at Frankfurt Airport. Photo: Boris Roessler/dpa via Getty Images

Countries across Europe and Asia are rushing through new travel restrictions in response to a new COVID variant identified by scientists in South Africa.

The big picture: Israel, Japan, the U.K., France, Germany, Italy and Singapore are moving to restrict entry from countries in the south of Africa, AP reports. Many are also adding quarantines for their own citizens upon return from the region.